These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 665427)

  • 21. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjects.
    Hindmarch I; Parrott AC; Arenillas L
    Br J Clin Pharmacol; 1977 Apr; 4(2):229-33. PubMed ID: 16635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chloral hydrate: a hypnotic best forgotten?].
    Gauillard J; Cheref S; Vacherontrystram MN; Martin JC
    Encephale; 2002; 28(3 Pt 1):200-4. PubMed ID: 12091779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of age and sex on human drug metabolism.
    O'Malley K; Crooks J; Duke E; Stevenson IH
    Br Med J; 1971 Sep; 3(5775):607-9. PubMed ID: 5569980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metabolism of hypnotic and sedative drugs in cholestasis (author's transl)].
    Denk H
    Z Gastroenterol; 1977 Jun; 15(6):373-7. PubMed ID: 888486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory action of cimetidine on antipyrine metabolism.
    Piekoszewski W; Rutkowska A; Brandys J
    Pol J Pharmacol; 1993; 45(4):421-9. PubMed ID: 8118484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Chloral Hydrate (Cas No. 302-17-0) in B6C3F1 mice (Gavage Studies).
    Natl Toxicol Program Tech Rep Ser; 2002 Feb; (502):1-197. PubMed ID: 11965861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.
    Krishnaswamy K; Naidu AN
    Br Med J; 1977 Feb; 1(6060):538-40. PubMed ID: 843795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of phenazone in patients with fast and slow euthyroidism after methimazole treatment].
    Wójcicki J; Górnik W; Syrenicz A; Gawrońska-Szklarz B; Czekalski S
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):131-3. PubMed ID: 2216952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schedule of controlled substances: placement of dichloralphenazone into Schedule IV. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2001 Aug; 66(159):42943-4. PubMed ID: 11794309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
    Abbas RR; Seckel CS; Kidney JK; Fisher JW
    Drug Metab Dispos; 1996 Dec; 24(12):1340-6. PubMed ID: 8971140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life threatening intracerebral hemorrhage with isometheptene mucate, dichlorophenazine and acetaminophen combination therapy.
    Johnston JC
    J Forensic Leg Med; 2009 Nov; 16(8):489-91. PubMed ID: 19782324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
    Adamska-Dyniewska H; Dziekański S; Pruszczyński J
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance.
    Elin RJ; Vesell ES; Wolff SM
    Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of chlorpromazine on drug metabolism.
    Stevenson IH; O'Malley K; Turnbull MJ; Ballinger BR
    J Pharm Pharmacol; 1972 Jul; 24(7):577-8. PubMed ID: 4403852
    [No Abstract]   [Full Text] [Related]  

  • 39. Phenazone (antipyrine) metabolism and distribution in young and elderly adults.
    Liddell DE; Williams FM; Briant RH
    Clin Exp Pharmacol Physiol; 1975; 2(6):481-7. PubMed ID: 1236602
    [No Abstract]   [Full Text] [Related]  

  • 40. Anomalous results of studies on drug interaction in man. I. Nortriptyline and antipyrine.
    Vesell ES; Passananti GT; Aurori KC
    Pharmacology; 1975; 13(2):101-11. PubMed ID: 49899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.